News
MRVI
3.680
+5.75%
0.200
Weekly Report: what happened at MRVI last week (0420-0424)?
Weekly Report · 3d ago
Maravai LifeSciences announces annual shareholder meeting webcast
PUBT · 6d ago
Maravai Lifesciences Holdings (MRVI) Gets a Buy from Craig-Hallum
TipRanks · 6d ago
Press Release: Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026
Dow Jones · 04/20 20:45
Maravai LifeSciences schedules quarterly results conference call and webcast
PUBT · 04/20 20:05
Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), Maravai Lifesciences Holdings (MRVI) and LENZ Therapeutics (LENZ)
TipRanks · 04/20 13:10
Weekly Report: what happened at MRVI last week (0413-0417)?
Weekly Report · 04/20 09:23
Weekly Report: what happened at MRVI last week (0406-0410)?
Weekly Report · 04/13 09:25
Weekly Report: what happened at MRVI last week (0330-0403)?
Weekly Report · 04/06 09:25
Weekly Report: what happened at MRVI last week (0323-0327)?
Weekly Report · 03/30 09:25
Weekly Report: what happened at MRVI last week (0316-0320)?
Weekly Report · 03/23 09:24
Weekly Report: what happened at MRVI last week (0309-0313)?
Weekly Report · 03/16 09:23
Weekly Report: what happened at MRVI last week (0302-0306)?
Weekly Report · 03/09 09:24
Weekly Report: what happened at MRVI last week (0223-0227)?
Weekly Report · 03/02 09:24
Maravai Lifesciences Charts Early Turnaround in 2025
TipRanks · 03/01 00:26
Maravai Lifesciences Holdings (MRVI) Receives a Buy from Stifel Nicolaus
TipRanks · 02/27 17:08
Maravai LifeSciences Holdings (MRVI) Posts US$130.8m TTM Loss Challenging Margin Recovery Narratives
Simply Wall St · 02/27 01:34
Maravai targets $200M–$210M 2026 revenue as restructuring drives early EBITDA turnaround
Seeking Alpha · 02/26 22:09
Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY) and Maravai Lifesciences Holdings (MRVI)
TipRanks · 02/26 16:40
Maravai Lifesciences price target raised to $3 from $2 at Baird
TipRanks · 02/26 15:20
More
Webull provides a variety of real-time MRVI stock news. You can receive the latest news about Maravai Lifesciences Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About MRVI
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. It serves various companies, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.